110953-39-4
Chemical Structure
3-Methyladenine-d3
- CAS No.: 110953-39-4
- Formula:C6H4D3N5
- Molecular Weight:152.17
IUPAC Name: 3-(methyl-d3)-3H-purin-6-amine
InChIKey: FSASIHFSFGAIJM-FIBGUPNXSA-N
SMILES: NC1=C2C(N(C=N1)C([2H])([2H])[2H])=NC=N2
Biological Activity: 3-Methyladenine-d3 is the deuterium labeled 3-Methyladenine[1]. 3-Methyladenine (3-MA) is a PI3K inhibitor. 3-Methyladenine is a widely used inhibitor of autophagy via its inhibitory effect on class III PI3K[2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
3-Methyladenine-d3 | 98.98% | 3-Methyladenine-d3 is the deuterium labeled 3-Methyladenine. 3-Methyladenine (3-MA) is a PI3K inhibitor. 3-Methyladenine is a widely used inhibitor of autophagy via its inhibitory effect on class III PI3K. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
3-Methyladenine (Standard) | ≥98% | 3-Methyladenine (Standard) is the analytical standard of 3-Methyladenine. This product is intended for research and analytical applications. 3-Methyladenine (3-MA) is a PI3K inhibitor. 3-Methyladenine is a widely used inhibitor of autophagy via its inhibitory effect on class III PI3K. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
3-Methyladenine-d3 hydroiodide | 3-Methyladenine-d3 (hydroiodide) is deuterated labeled 3-Methyladenine. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
3-Methyladenine | 99.91% | 3-Methyladenine (3-MA) is a PI3K inhibitor. 3-Methyladenine is a widely used inhibitor of autophagy via its inhibitory effect on class III PI3K. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
- [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [Content Brief]
- [2]. Miller S, et al. Finding a fitting shoe for Cinderella: searching for an autophagy inhibitor. Autophagy. 2010 Aug;6(6):805-7. [Content Brief]